Contract development and manufacturing organizations looking to do business with biopharmas include Lonza, which has more than 30 sites, and Samsung Biologics, which recently announced a planned acquisition of another CDMO.
Source: Biospace
This item was collected automatically from an official industry feed. Follow the source link for the complete announcement and primary documentation.